{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:57:47Z","timestamp":1771660667530,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00415-008-0815-9","type":"journal-article","created":{"date-parts":[[2008,8,2]],"date-time":"2008-08-02T13:17:19Z","timestamp":1217683039000},"page":"917-924","source":"Crossref","is-referenced-by-count":14,"title":["Intrathecal anti-\u03b1B-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"255","author":[{"given":"Julia","family":"Wanschitz*","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Ehling*","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang N.","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betinna","family":"K\u00fcnz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Deisenhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Budka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,11]]},"reference":[{"key":"815_CR1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990)Assessment of current diagnosticcriteria for Guillain-Barr\u00e9 syndrome.Ann Neurol 27(Suppl):S21\u2013S24","journal-title":"Ann Neurol"},{"key":"815_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s004150070049","volume":"247","author":"Celet","year":"2000","unstructured":"Celet B, Akman-Demir G, Serdaroglu P,Yentur SP, Tasci B, van Noort JM,Eraksoy M, Saruhan-Direskeneli G(2000) Anti-alpha B-crystallin immunoreactivityin inflammatory nervoussystem diseases. J Neurol 247:935\u2013939","journal-title":"J Neurol"},{"key":"815_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/glia.20309","volume":"53","author":"D\u2019Antonio","year":"2006","unstructured":"D\u2019Antonio M, Michalovich D, PatersonM, Droggiti A, Woodhoo A, Mirsky R,Jessen KR (2006) Gene profiling andbioinformatic analysis of Schwann cellembryonic development and myelination.Glia 53:501\u2013515","journal-title":"Glia"},{"key":"815_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","volume":"13","author":"Deisenhammer","year":"2006","unstructured":"Deisenhammer F, Bartos A, Egg R,Gilhus NE, Giovannoni G, Rauer S,Sellebjerg F (2006) Guidelines onroutine cerebrospinal fluid analysis.Report from an EFNS task force. Eur JNeurol 13:913\u2013922","journal-title":"Eur JNeurol"},{"key":"815_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-5728(96)00029-X","volume":"66","author":"Deisenhammer","year":"1996","unstructured":"Deisenhammer F, Keir G, Pfausler B,Thompson EJ (1996) Affinity of anti-GM1 antibodies in Guillain-Barr\u00e9syndrome patients. J Neuroimmunol66:85\u201393","journal-title":"J Neuroimmunol"},{"key":"815_CR6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jnr.20310","volume":"78","author":"Duvanel","year":"2004","unstructured":"Duvanel CB, Monnet-Tschudi F,Braissant O, Matthieu JM, Honegger P(2004) Tumor necrosis factor-alphaand alphaB-crystallin up-regulationduring antibody-mediated demyelinationin vitro: a putative protectivemechanism in oligodendrocytes.J Neurosci Res 78:711\u2013722","journal-title":"J Neurosci Res"},{"key":"815_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.58.6.913","volume":"58","author":"Gordon","year":"2001","unstructured":"Gordon PH, Wilbourn AJ (2001) Earlyelectrodiagnostic findings in Guillain-Barr\u00e9 syndrome. Arch Neurol 58:913\u2013917","journal-title":"Arch Neurol"},{"key":"815_CR8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, HughesRA, Zielasek J, Hartung HP, Toyka KV,Swan AV (1998) Electrophysiologicalclassification of Guillain-Barr\u00e9 syndrome:clinical associations and outcome.Plasma Exchange\/SandoglobulinGuillain-Barr\u00e9 Syndrome TrialGroup. Ann Neurol 44:780\u2013788","journal-title":"Ann Neurol"},{"key":"815_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"Hahn","year":"1998","unstructured":"Hahn AF (1998) Guillain-Barr\u00e9syndrome. Lancet 352:635\u2013641","journal-title":"Lancet"},{"key":"815_CR10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/381571a0","volume":"381","author":"Hartl","year":"1996","unstructured":"Hartl FU (1996) Molecular chaperonesin cellular protein folding. Nature 381:571\u2013579","journal-title":"Nature"},{"key":"815_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jcp.1041590107","volume":"159","author":"Head","year":"1994","unstructured":"Head MW, Corbin E, Goldman JE(1994) Coordinate and independentregulation of alpha B-crystallin andhsp27 expression in response to physiologicalstress. J Cell Physiol 159:41\u201350","journal-title":"J Cell Physiol"},{"key":"815_CR12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/01.WNL.0000153071.71335.E9","volume":"64","author":"Hiraga","year":"2005","unstructured":"Hiraga A, Kuwabara S, Ogawara K,Misawa S, Kanesaka T, Koga M, Yuki N,Hattori T, Mori M (2005) Patterns andserial changes in electrodiagnosticabnormalities of axonal Guillain-Barr\u00e9syndrome. Neurology 64:856\u2013860","journal-title":"Neurology"},{"key":"815_CR13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"Hughes","year":"2005","unstructured":"Hughes RAC, Cornblath DR (2005)Guillain-Barr\u00e9 syndrome. Lancet366:1653\u20131666","journal-title":"Lancet"},{"key":"815_CR14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"Hughes","year":"1978","unstructured":"Hughes RAC, Newsom-Davis JM,Perkin GD, Pierce JM (1978) Controlledtrial prednisolone in acutepolyneuropathy. Lancet 2:750\u2013753","journal-title":"Lancet"},{"key":"815_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/513793","volume":"176","author":"Hughes","year":"1997","unstructured":"Hughes RAC, Rees JH (1997) Clinicaland epidemiologic features of Guillain-Barr\u00e9 syndrome. J Infect Dis176(Suppl 2):92\u201398","journal-title":"J Infect Dis"},{"key":"815_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/38.1.2294148","volume":"38","author":"Iwaki","year":"1990","unstructured":"Iwaki T, Kume-Iwaki A, Goldman JE(1990) Cellular distribution of alphaB-crystallin in non-lenticular tissues.J Histochem Cytochem 38:31\u201339","journal-title":"J Histochem Cytochem"},{"key":"815_CR17","doi-asserted-by":"crossref","first-page":"38731","DOI":"10.1074\/jbc.M201770200","volume":"277","author":"Kamradt","year":"2002","unstructured":"Kamradt MC, Chen F, Sam S, Cryns VL(2002) The small heat shock proteinalpha B-crystallin negatively regulatesapoptosis during myogenic differentiationby inhibiting caspase-3 activation.J Biol Chem 277:38731\u201338736","journal-title":"J Biol Chem"},{"key":"815_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","volume":"30","author":"Kieseier","year":"2004","unstructured":"Kieseier BC, Kiefer R, Gold R, HemmerB, Willison HJ, Hartung HP (2004)Advances in understanding and treatmentof immune-mediated disordersof the peripheral nervous system.Muscle Nerve 30:131\u2013156","journal-title":"Muscle Nerve"},{"key":"815_CR19","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.88.9.3652","volume":"88","author":"Klemenz","year":"1991","unstructured":"Klemenz R, Frohli E, Steiger RH,Schafer R, Aoyama A (1991) Alpha Bcrystallinis a small heat shock protein.Proc Natl Acad Sci USA 88:3652\u20133656","journal-title":"Proc Natl Acad Sci USA"},{"key":"815_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pep.2003.11.016","volume":"34","author":"Linares","year":"2004","unstructured":"Linares D, Echevarria I, Mana P (2004)Single-step purification and refoldingof recombinant mouse and humanmyelin oligodendrocyte glycoproteinand induction of EAE in mice. ProteinExpr Purif 34:249\u2013256","journal-title":"ProteinExpr Purif"},{"key":"815_CR21","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/j.1460-2075.1996.tb00630.x","volume":"15","author":"Mehlen","year":"1996","unstructured":"Mehlen P, Kretz-Remy C, Preville X,Arrigo AP (1996) Human hsp27,Drosophila hsp27 and human alphaB-crystallinexpression-mediated increasein glutathione is essential forthe protective activity of these proteinsagainst TNF-alpha-induced cell death.Embo J 15:2695\u20132706","journal-title":"Embo J"},{"key":"815_CR22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/nm962","volume":"9","author":"Millar","year":"2003","unstructured":"Millar DG, Garza KM, Odermatt B,Elford AR, Ono N, Li Z, Ohashi PS(2003) Hsp70 promotes antigen-presentingcell function and converts Tcelltolerance to autoimmunity in vivo.Nat Med 9:1469\u20131476","journal-title":"Nat Med"},{"key":"815_CR23","doi-asserted-by":"crossref","unstructured":"Ousman SS, Tomooka BH, van NoortJM, Wawrousek EF, O\u2019Conner K, HaflerDA, Sobel RA, Robinson WH, SteinmanL (2007) Protective and therapeuticrole for alphaB-crystallin in autoimmunedemyelination. Nature (Epubahead of print)","DOI":"10.1038\/nature05935"},{"key":"815_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458506072189","volume":"13","author":"Pittock","year":"2007","unstructured":"Pittock SJ, Reindl M, Achenbach S,Berger T, Br\u00fcck W, Konig F, Morales Y,Lassmann H, Bryant S, Moore SB,Keegan BM, Lucchinetti CF (2007)Myelin oligodendrocyte glycoproteinantibodies in pathologically provenmultiple sclerosis: frequency, stabilityand clinicopathologic correlations.Mult Scler 13:7\u201316","journal-title":"Mult Scler"},{"key":"815_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","volume":"362","author":"Pockley","year":"2003","unstructured":"Pockley AG (2003) Heat shock proteinsas regulators of the immune response.Lancet 362:469\u2013476","journal-title":"Lancet"},{"key":"815_CR26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","volume":"326","author":"Ropper","year":"1992","unstructured":"Ropper AH (1992) The Guillain-Barr\u00e9syndrome. N Engl J Med 326:1130\u20131136","journal-title":"N Engl J Med"},{"key":"815_CR27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/375798a0","volume":"375","author":"van Noort","year":"1995","unstructured":"van Noort JM, van Sechel AC,Bajramovic JJ, el Ouagmiri M, PolmanCH, Lassmann H, Ravid R (1995) Thesmall heat-shock protein alpha B-crystallinas candidate autoantigen in multiplesclerosis. Nature 375:798\u2013801","journal-title":"Nature"},{"key":"815_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","volume":"162","author":"van Sechel","year":"1999","unstructured":"van Sechel AC, Bajramovic JJ, vanStipdonk MJ, Persoon-Deen C,Geutskens SB, van Noort JM (1999)EBV-induced expression and HLA-DR-restrictedpresentation by human Bcells of alpha B-crystallin, a candidateautoantigen in multiple sclerosis.J Immunol 162:129\u2013135","journal-title":"J Immunol"},{"key":"815_CR29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1523\/JNEUROSCI.4235-04.2005","volume":"25","author":"Willis","year":"2005","unstructured":"Willis D, Li KW, Zheng JQ, Chang JH,Smit A, Kelly T, Merianda TT, SylvesterJ, van Minnen J, Twiss JL (2005) Differentialtransport and local translationof cytoskeletal, injury-response, andneurodegeneration protein mRNAs inaxons. J Neurosci 25:778\u2013791","journal-title":"J Neurosci"},{"key":"815_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","volume":"10","author":"Willison","year":"2005","unstructured":"Willison HJ (2005) The immunobiologyof Guillain-Barr\u00e9 syndromes.J Peripher Nerv Syst 10:94\u2013112","journal-title":"J Peripher Nerv Syst"},{"key":"815_CR31","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"Willison","year":"2002","unstructured":"Willison HJ, Yuki N (2002) Peripheralneuropathies and anti-glycolipid antibodies.Brain 125:2591\u20132625","journal-title":"Brain"},{"key":"815_CR32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2004.07.017","volume":"156","author":"Yonekura","year":"2004","unstructured":"Yonekura K, Yokota S, Tanaka S,Kubota H, Fujii N, Matsumoto H,Chiba S (2004) Prevalence of anti-heatshock protein antibodies in cerebrospinalfluids of patients with Guillain-Barr\u00e9 syndrome. J Neuroimmunol156:204\u2013209","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0815-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0815-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0815-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:14:11Z","timestamp":1684498451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0815-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0815-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}